Publicly Traded Cannabis Stock News

Aphria Q4 Sales Rise 106%

EBITDA increases 181% in the quarter, exceeding $2.8 million Cash costs to produce dried cannabis per gram decreases 35% from prior quarter LEAMINGTON, ONTARIO–(Marketwired – July 12, 2017) –...
- July 12th, 2017 at 8:23 am

TerrAscend’s Solace Health Receives Cannabis Cultivation License

TerrAscend’s Wholly-Owned Subsidiary, Solace Health Inc., Obtains License to Cultivate Medical Cannabis TORONTO, July 10, 2017 (GLOBE NEWSWIRE) — TerrAscend Corp. (CSE: TER) (“TerrAscend” or the “Company”), is pleased to announce...
- July 10th, 2017 at 4:59 pm

Aurora Cannabis to Graduate to TSX

VANCOUVER, July 10, 2017 /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that the Company has received conditional...
- July 10th, 2017 at 7:50 am

How BCC is Rolling Up the U.S Cannabis Industry

Civilized continued its excellent “C-Suite” series of interviews with leading cannabis industry executives, interviewing Scott Boyes, CEO of The Canadian Bioceutical Corporation (CSE: BCC) (OTC: CBICF), which is rapidly...
- July 7th, 2017 at 1:53 pm

Aphria to Supply 25K Cannabis Plants to Scientus Pharma

Aphria Inks Major Wholesale Supply Agreement With Scientus Pharma, Health Canada Licensed Dealer Agreement to generate approximately $5 million in revenue for Aphria over 12-month contract LEAMINGTON, ONTARIO–(Marketwired –...
- July 4th, 2017 at 8:41 am

Cannabis Extracts: The Next Canadian Oil Boom

Canada’s medical cannabis market began as a flower-only market, but, following a court ruling, the licensed producers (LPs) were permitted to begin producing extracts in late 2015. While these products...
- July 2nd, 2017 at 4:37 pm

Aurora Cannabis Oils Drive Record Monthly Sales

Operational Update: Aurora Cannabis Surpasses 16,000 Registered Patients; Launch of Cannabis Oils Drives Record Monthly Revenue VANCOUVER, June 29, 2017 /CNW/ – Aurora Cannabis Inc. (“Aurora” or the “Company”)...
- June 29th, 2017 at 7:40 am

MedReleaf reports Q4 Sales of $10.4mm

MedReleaf Reports Fourth Quarter and Fiscal Year 2017 Results Fiscal 2017 Adjusted EBITDA of $14 million on $40 million in sales; phase 1 Bradford Facility expansion complete and in...
- June 28th, 2017 at 7:49 am